Literature DB >> 15476313

The rediscovery of ancient Chinese herbal formulas.

Wei Jia1, Wen-Yuan Gao, Yong-Qing Yan, Jie Wang, Zhao-Hui Xu, Wen-Jie Zheng, Pei-Gen Xiao.   

Abstract

This review presents some recent discoveries of ancient Chinese herbal formulas evolved through thousands of years of clinical practice. It appears that many of the ancient combination formulas have sound scientific basis through modern pharmacological evaluation. Significant chemical changes occurred during the preparation (decoction) process of a prescribed herbal formula. For example, some toxic ingredients were significantly reduced and new active compounds generated due to the chemical interactions among the ingredients. Many combination formulas showed significantly better pharmacological results than individual herbal medicines participated in the formula. These findings suggest that the current drug screening and regulatory methodology will not be appropriate for the development of a botanical drug containing a group of phytochemicals, in which a synergistic interaction from chemical ingredients plays a fundamental role in the treatment of disease. If we view a diseased state in a holistic and dynamic way, i.e. it involves interactions among many biological systems in human body and these interactions change as the disease improves or worsens, the treatment of such disease with a single chemical entity may not be logical or technically feasible. Combination formulas may hold the potential to become the therapeutics of choice in the future due to the synergistic effect and dynamic adjustment achieved by the multiple ingredients that will restore the balance of an imbalanced or diseased human body. Copyright (c) 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15476313     DOI: 10.1002/ptr.1506

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  30 in total

1.  The Influence of Compatibility of Rhubarb and Radix Scutellariae on the Pharmacokinetics of Anthraquinones and Flavonoids in Rat Plasma.

Authors:  Yaqing Zhang; Zunjian Zhang; Rui Song
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-06       Impact factor: 2.441

2.  A Comparison Study on Traditional Mixtures of Herbal Teas Used in Eastern Mediterranean Area.

Authors:  Concepción Obón; Diego Rivera; Elena Fonollá; Francisco Alcaraz; Latifa Attieh
Journal:  Front Pharmacol       Date:  2021-04-23       Impact factor: 5.810

3.  Management of hepatic encephalopathy by traditional chinese medicine.

Authors:  Chun Yao; Nong Tang; Guoxiang Xie; Xiaojiao Zheng; Ping Liu; Lei Fu; Wu Xie; Fan Yao; Houkai Li; Wei Jia
Journal:  Evid Based Complement Alternat Med       Date:  2012-03-05       Impact factor: 2.629

4.  Proteomic analysis of the effect of fuzheng huayu recipe on fibrotic liver in rats.

Authors:  Hongdong Xie; Yanyan Tao; Jing Lv; Ping Liu; Chenghai Liu
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-29       Impact factor: 2.629

5.  New perspectives on chinese herbal medicine (zhong-yao) research and development.

Authors:  Si-Yuan Pan; Si-Bao Chen; Hong-Guang Dong; Zhi-Ling Yu; Ji-Cui Dong; Zhi-Xian Long; Wang-Fun Fong; Yi-Fan Han; Kam-Ming Ko
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-10       Impact factor: 2.629

6.  Molecular Mechanisms of Same TCM Syndrome for Different Diseases and Different TCM Syndrome for Same Disease in Chronic Hepatitis B and Liver Cirrhosis.

Authors:  Zhizhong Guo; Shuhao Yu; Yan Guan; Ying-Ya Li; Yi-Yu Lu; Hui Zhang; Shi-Bing Su
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-30       Impact factor: 2.629

7.  Fuzheng Huayu recipe prevents nutritional fibrosing steatohepatitis in mice.

Authors:  Yan-Hong Jia; Rong-Qi Wang; Hong-Mei Mi; Ling-Bo Kong; Wei-Guang Ren; Wen-Cong Li; Su-Xian Zhao; Yu-Guo Zhang; Wen-Juan Wu; Yue-Min Nan; Jun Yu
Journal:  Lipids Health Dis       Date:  2012-03-28       Impact factor: 3.876

8.  Effect of Fuzheng Huayu formula and its actions against liver fibrosis.

Authors:  Chenghai Liu; Yiyang Hu; Lieming Xu; Cheng Liu; Ping Liu
Journal:  Chin Med       Date:  2009-06-29       Impact factor: 5.455

9.  Progression from Excessive to Deficient Syndromes in Chronic Hepatitis B: A Dynamical Network Analysis of miRNA Array Data.

Authors:  Qi-Long Chen; Yi-Yu Lu; Gui-Biao Zhang; Ya-Nan Song; Qian-Mei Zhou; Hui Zhang; Wei Zhang; Shi-Bing Su
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-16       Impact factor: 2.629

Review 10.  Deep sea as a source of novel-anticancer drugs: update on discovery and preclinical/clinical evaluation in a systems medicine perspective.

Authors:  Patrizia Russo; Alessandra Del Bufalo; Massimo Fini
Journal:  EXCLI J       Date:  2015-02-10       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.